Atlas Capital Advisors’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.3K | Hold |
1,234
| – | – | ﹤0.01% | 744 |
|
|
2025
Q1 | $10.8K | Hold |
1,234
| – | – | ﹤0.01% | 796 |
|
|
2024
Q4 | $17.7K | Buy |
+1,234
| New | +$17.7K | ﹤0.01% | 733 |
|
|
2024
Q3 | – | Sell |
-1,234
| Closed | -$24K | – | 959 |
|
|
2024
Q2 | $24K | Sell |
1,234
-700
| -36% | -$13.6K | ﹤0.01% | 674 |
|
|
2024
Q1 | $72.6K | Hold |
1,934
| – | – | 0.01% | 519 |
|
|
2023
Q4 | $108K | Buy |
1,934
+240
| +14% | +$13.4K | 0.02% | 484 |
|
|
2023
Q3 | $69.9K | Hold |
1,694
| – | – | 0.01% | 501 |
|
|
2023
Q2 | $94.6K | Hold |
1,694
| – | – | 0.01% | 482 |
|
|
2023
Q1 | $94.5K | Buy |
1,694
+166
| +11% | +$9.26K | 0.01% | 473 |
|
|
2022
Q4 | $55.7K | Buy |
1,528
+168
| +12% | +$6.12K | 0.01% | 527 |
|
|
2022
Q3 | $38.7K | Buy |
1,360
+425
| +45% | +$12.1K | 0.01% | 570 |
|
|
2022
Q2 | $42.3K | Buy |
935
+275
| +42% | +$12.4K | 0.01% | 586 |
|
|
2022
Q1 | $50.2K | Hold |
660
| – | – | 0.01% | 545 |
|
|
2021
Q4 | $98.3K | Hold |
660
| – | – | 0.01% | 458 |
|
|
2021
Q3 | $96.1K | Hold |
660
| – | – | 0.02% | 448 |
|
|
2021
Q2 | $129K | Hold |
660
| – | – | 0.02% | 420 |
|
|
2021
Q1 | $119K | Hold |
660
| – | – | 0.02% | 398 |
|
|
2020
Q4 | $93.5K | Buy |
+660
| New | +$93.5K | 0.02% | 402 |
|